SEATTLE--(BUSINESS WIRE)--Theraclone Sciences, a biopharmaceutical company formerly known as Spaltudaq, focused on the discovery and development of human antibodies, announced results from its HIV antibody discovery program at the HIV Immunobiology Meeting of the Keystone Symposia Global Health Series earlier this week.
